 |
Granulocyte macrophage-colony stimulating factor |
|---|---|
| Trade Name | Leucomax |
| Orphan Indication | Severe thermal injuries in patients with greater than 40% full or partial thickness burns |
| USA Market Approval | USA |
| USA Designation Date | 1989-06-06 00:00:00 |
| Sponsor | Schering Corporation;2000 Galloping Hill Road;Kenilworth, New Jersey, 07033 |
